Aristotle University Of Thessaloniki (AUTH)
Η επίδραση των επιλεκτικών ρυθμιστών των υποδοχέων των οιστρογόνων στον άξονα υποθάλαμος - υπόφυση - όρχεις
Abstract
dc:descriptionThe present study was designed in order to evaluate, compare and contrast the effects of three selective estrogen receptor modulators (SERMs), namely tamoxifen, toremifen and raloxifen on the hypothalamic-pituitary-testicular axis in subfertile men with idiopathic oligozoospermia. Two-hundred and eighty-four (284) men were consecutively assigned to three therapeutic protocols: I. tamoxifen, 20 mg o.d. (n=94) II. toremifen, 60 mg o.d. (n=99) III. raloxifen, 60 mg o.d. (n=91). At baseline and at the end of the first, second and third month of treatment, circulating levels of FSH, LH, PRL, T and SHBG were measured and the free androgen index (FAI) was calculated. Statistical analyses were performed with General Linear Model (GLM) – based repeated measures 2-way AN(C)OVA. The results showed that: 1) Age was positively correlated with basal SHBG levels and negatively correlated with basal T levels and FAI values. 2) The body mass index (BMI) was negatively correlated with T and SHBG concentrations at baseline. 3) FSH, LH, T and SHBG levels were significantly increased, while PRL levels were significantly decreased in men who received tamoxifen or raloxifen, and these changes were most marked during the first month. 4) The increase in FSH, LH and T levels was significantly less marked in the raloxifen group; moreover, in the latter group, SHBG levels were significantly decreased, whereas PRL levels were significantly increased. 5) FAI values were significantly increased in all three groups, during the first month of treatment in the tamoxifen and toremifen groups and during the second in the raloxifen group; no significant difference in FAI values at the end of treatment was observed between the three groups. The conclusions were that: a) The anti-estrogenic effects of SERMs at the hypothalamic level result in a significant increase of gonadotropin levels, which is more marked for tamoxifen and toremifen, compared to raloxifen. b) The increase in SHBG levels should be attributed to the estrogenic properties of tamoxifen and toremifen at the liver, whereas, on the contrary, raloxifen seems to exert an anti-estrogenic effect. c) The greater increase in T levels after administration of tamoxifen and toremifen, compared to raloxifen should be attributed to the greater stimulation of gonadotropin secretion, although a direct effect on the testis cannot be excluded. d) No difference between the three SERMs was observed, regarding free circulating testosterone, reflected in FAI values, at the end of treatment.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tsourdi, Eleni
- Τσουρδή, Ελένη
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/22100